| scholarly article | Q13442814 |
| P50 | author | Ben Bax | Q67804404 |
| P2093 | author name string | M. J. Brown | |
| A. D. Reith | |||
| T. Hagen | |||
| D. A. Cross | |||
| S. Frame | |||
| A. A. Culbert | |||
| P2860 | cites work | AD2, a phosphorylation-dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease | Q71525713 |
| Recognition of the minimal epitope of monoclonal antibody Tau‐1 depends upon the presence of a phosphate group but not its location | Q72073020 | ||
| Purification of Glycogen Synthase Kinase 3 from Rabbit Skeletal Muscle.. Copurification with the Activating Factor (FA)of the (Mg-ATP) Dependent Protein Phosphatase | Q72914857 | ||
| Insulin activates protein kinase B, inhibits glycogen synthase kinase-3 and activates glycogen synthase by rapamycin-insensitive pathways in skeletal muscle and adipose tissue | Q73241292 | ||
| Role of glycogen synthase kinase-3beta in neuronal apoptosis induced by trophic withdrawal | Q73575616 | ||
| Differential molecular interactions of beta-catenin and plakoglobin in adhesion, signaling and cancer | Q77565725 | ||
| The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bepsilon at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase | Q24291138 | ||
| GBP, an Inhibitor of GSK-3, Is Implicated in Xenopus Development and Oncogenesis | Q24309150 | ||
| Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta -catenin and promotes GSK-3beta -dependent phosphorylation of beta -catenin | Q24313571 | ||
| Downregulation of β-catenin by human Axin and its association with the APC tumor suppressor, β-catenin and GSK3β | Q24319688 | ||
| Signal transduction by the Wnt family of ligands | Q24530639 | ||
| Activation of a novel proto-oncogene, Frat1, contributes to progression of mouse T-cell lymphomas | Q24532079 | ||
| Axin and Frat1 interact with dvl and GSK, bridging Dvl to GSK in Wnt-mediated regulation of LEF-1. | Q24534260 | ||
| A simplified system for generating recombinant adenoviruses | Q24682328 | ||
| A genetic model for colorectal tumorigenesis | Q27860582 | ||
| Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B | Q27860731 | ||
| A GSK3-binding peptide from FRAT1 selectively inhibits the GSK3-catalysed phosphorylation of axin and beta-catenin | Q28115262 | ||
| The Hormonal Control of Glycogen Metabolism in Mammalian Muscle by Multivalent Phosphorylation | Q28254330 | ||
| Overexpression of the mouse dishevelled-1 protein inhibits GSK-3beta-mediated phosphorylation of tau in transfected mammalian cells | Q28504627 | ||
| Wnt-induced dephosphorylation of axin releases beta-catenin from the axin complex | Q28609062 | ||
| Interaction among GSK-3, GBP, axin, and APC in Xenopus axis specification | Q28640539 | ||
| Glycogen Synthase from Rabbit Skeletal Muscle | Q29301807 | ||
| Wnt signaling: a common theme in animal development | Q29547527 | ||
| Wnt signaling in oncogenesis and embryogenesis--a look outside the nucleus | Q29620188 | ||
| Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription | Q31462537 | ||
| Mechanism and function of signal transduction by the Wnt/beta-catenin and Wnt/Ca2+ pathways | Q33814311 | ||
| Regulation of glycogen synthase kinase 3beta and downstream Wnt signaling by axin | Q33959834 | ||
| Neuronal death and GSK-3beta: a tau fetish? | Q34224603 | ||
| Regulation of GSK-3: a cellular multiprocessor | Q34299875 | ||
| Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice | Q34449486 | ||
| Bridging of β-catenin and glycogen synthase kinase-3β by Axin and inhibition of β-catenin-mediated transcription | Q35977699 | ||
| Domains of tau protein, differential phosphorylation, and dynamic instability of microtubules | Q40665458 | ||
| Tau phosphorylation at serine 396 and serine 404 by human recombinant tau protein kinase II inhibits tau's ability to promote microtubule assembly | Q40878824 | ||
| Interaction of axin and Dvl-2 proteins regulates Dvl-2-stimulated TCF-dependent transcription. | Q40954159 | ||
| Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells. | Q41423732 | ||
| Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death | Q43560460 | ||
| Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons | Q48658321 | ||
| The effect of tau antisense oligonucleotides on neurite formation of cultured cerebellar macroneurons. | Q48712746 | ||
| Nerve growth factor induces survival and differentiation through two distinct signaling cascades in PC12 cells | Q52177288 | ||
| Glycogen synthase kinase-3 beta activity is critical for neuronal death caused by inhibiting phosphatidylinositol 3-kinase or Akt but not for death caused by nerve growth factor withdrawal | Q54415298 | ||
| Phosphorylation Sites on Tau Identified by Nanoelectrospray Mass Spectrometry | Q55919559 | ||
| Glycogen Synthase Kinase-3 from Rabbit Skeletal Muscle | Q56456617 | ||
| Phosphorylation of tau protein by recombinant GSK-3beta: pronounced phosphorylation at select Ser/Thr-Pro motifs but no phosphorylation at Ser262 in the repeat domain | Q60603639 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Adenoviridae | Q193447 |
| transport protein | Q2111029 | ||
| neoplasm protein | Q66894191 | ||
| SB-415286 | Q27088727 | ||
| overexpression | Q61643320 | ||
| P304 | page(s) | 288-294 | |
| P577 | publication date | 2001-11-01 | |
| 2001-11-02 | |||
| P1433 | published in | FEBS Letters | Q1388051 |
| P1476 | title | GSK-3 inhibition by adenoviral FRAT1 overexpression is neuroprotective and induces Tau dephosphorylation and beta-catenin stabilisation without elevation of glycogen synthase activity | |
| GSK‐3 inhibition by adenoviral FRAT1 overexpression is neuroprotective and induces Tau dephosphorylation and β‐catenin stabilisation without elevation of glycogen synthase activity | |||
| P478 | volume | 507 |
| Q42119593 | Anti-inflammatory activity of Wnt signaling in enteric nervous system: in vitro preliminary evidences in rat primary cultures |
| Q24317033 | Axin negatively affects tau phosphorylation by glycogen synthase kinase 3beta |
| Q48448864 | Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling. |
| Q44135113 | Central role of glycogen synthase kinase-3beta in endoplasmic reticulum stress-induced caspase-3 activation |
| Q44400926 | Ceramide-induced neuronal apoptosis is associated with dephosphorylation of Akt, BAD, FKHR, GSK-3β, and induction of the mitochondrial-dependent intrinsic caspase pathway |
| Q37204595 | Characterization of the interaction between latency-associated nuclear antigen and glycogen synthase kinase 3beta |
| Q35612223 | Characterization of the role of COP9 signalosome in regulating cullin E3 ubiquitin ligase activity |
| Q26865911 | Current Understanding on EGFR and Wnt/β-Catenin Signaling in Glioma and Their Possible Crosstalk |
| Q50884859 | Differential effects of glycogen synthase kinase 3 (GSK3) inhibition by lithium or selective inhibitors in the central nervous system. |
| Q42808062 | Discovery of Novel GSK-3β Inhibitors with Potent in Vitro and in Vivo Activities and Excellent Brain Permeability Using Combined Ligand- and Structure-Based Virtual Screening |
| Q41878659 | Downregulation of Mcl-1 through GSK-3β activation contributes to arsenic trioxide-induced apoptosis in acute myeloid leukemia cells |
| Q54561008 | Effect of double mutations K214/A–E215/Q of FRATide on GSK3β: insights from molecular dynamics simulation and normal mode analysis |
| Q44904081 | Endogenous IGF-I protects human intestinal smooth muscle cells from apoptosis by regulation of GSK-3 beta activity |
| Q33183622 | Expression and characterization of GSK-3 mutants and their effect on beta-catenin phosphorylation in intact cells |
| Q28291371 | FRAT-2 preferentially increases glycogen synthase kinase 3 beta-mediated phosphorylation of primed sites, which results in enhanced tau phosphorylation |
| Q34566865 | FRAT1, a substrate-specific regulator of glycogen synthase kinase-3 activity, is a cellular substrate of protein kinase A. |
| Q21129334 | GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS |
| Q27642879 | GSK-3-selective inhibitors derived from Tyrian purple indirubins |
| Q44627005 | GSK-3β Inhibition Induced Neuroprotection, Regeneration, and Functional Recovery After Intracerebral Hemorrhagic Stroke |
| Q37608407 | GSK-3β protein phosphorylates and stabilizes HLXB9 protein in insulinoma cells to form a targetable mechanism of controlling insulinoma cell proliferation |
| Q21285144 | GSK-3β: A Bifunctional Role in Cell Death Pathways |
| Q34732988 | Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation |
| Q42472820 | Glycogen synthase kinase 3 has a proapoptotic function in Hydra gametogenesis |
| Q41447595 | In vivo regulation of glycogen synthase kinase 3β activity in neurons and brains |
| Q37388842 | Increased concentrations of fructose 2,6-bisphosphate contribute to the Warburg effect in phosphatase and tensin homolog (PTEN)-deficient cells. |
| Q35090349 | Inhibition of adipocytogenesis by canonical WNT signaling in human mesenchymal stem cells |
| Q33580209 | Inhibition of hypoxia-inducible factor-1alpha (HIF-1alpha) protein synthesis by DNA damage inducing agents |
| Q38078976 | Insulin resistance and adipogenesis: Role of transcription and secreted factors |
| Q35661658 | Lithium blocks the c-Jun stress response and protects neurons via its action on glycogen synthase kinase 3. |
| Q34387857 | Mechanism of Cullin3 E3 Ubiquitin Ligase Dimerization |
| Q52609485 | Mechanism of kinase inactivation and nonbinding of fratide to GSK3β due to K85M mutation: Molecular dynamics simulation and normal mode analysis |
| Q57340466 | Nanoparticles for Stem-Cell Engineering |
| Q38561833 | Nucleosomes structure and dynamics: effect of CHAPS. |
| Q39494690 | Overexpression of Frat1 correlates with malignant phenotype and advanced stage in human non-small cell lung cancer |
| Q54408272 | PLS and shape-based similarity analysis of maleimides--GSK-3 inhibitors |
| Q39008696 | Pharmacophore-based screening and drug repurposing exemplified on glycogen synthase kinase-3 inhibitors. |
| Q42722184 | Phosphorylation of PPP(S/T)P motif of the free LRP6 intracellular domain is not required to activate the Wnt/beta-catenin pathway and attenuate GSK3beta activity |
| Q36057317 | Protein Profile and Morphological Alterations in Penumbra after Focal Photothrombotic Infarction in the Rat Cerebral Cortex. |
| Q52729737 | RNA sequencing reveals widespread transcriptome changes in a renal carcinoma cell line. |
| Q24317967 | Regulation of Cullin-RING ubiquitin ligase 1 by Spliceosome-associated protein 130 (SAP130) |
| Q24337729 | Regulation of cullin RING E3 ubiquitin ligases by CAND1 in vivo |
| Q50527297 | Regulation of stem cell signaling by nanoparticle-mediated intracellular protein delivery |
| Q36222556 | Reproductive Stage and Modulation of Stress-Induced Tau Phosphorylation in Female Rats. |
| Q40597673 | Signalling activity of beta-catenin targeted to different subcellular compartments |
| Q28298285 | Substrate-mediated regulation of cullin neddylation |
| Q28265036 | Suppression of androgen receptor-mediated transactivation and cell growth by the glycogen synthase kinase 3 beta in prostate cells |
| Q27636657 | The Structure of Phosphorylated GSK-3β Complexed with a Peptide, FRATtide, that Inhibits β-Catenin Phosphorylation |
| Q41846475 | The Wnt antagonist Dickkopf-1 and its receptors are coordinately regulated during early human adipogenesis. |
| Q24299312 | The low density lipoprotein receptor-related protein 6 interacts with glycogen synthase kinase 3 and attenuates activity |
| Q37345648 | The marine natural-derived inhibitors of glycogen synthase kinase-3beta phenylmethylene hydantoins: In vitro and in vivo activities and pharmacophore modeling |
| Q35103813 | The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways |
| Q37838910 | The role of selective transport in neuronal polarization |
| Q60046118 | Tideglusib Rescues Neurite Pathology of SPG11 iPSC Derived Cortical Neurons |
| Q30494084 | Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease |
| Q34494404 | WNT10B mutations in human obesity. |
Search more.